Literature DB >> 20037190

Haloperidol moderately inhibits cardiovascular L-type calcium current.

Bohumila Tarabová1, Marie Nováková, L'ubica Lacinová.   

Abstract

Effects of haloperidol on L-type CaV1.2 channel were studied. Calcium current was measured in whole cell patch-clamp using calcium as a charge carrier. Inhibition by haloperidol was investigated in CaV1.2 channel natively expressed in rat cardiac myocytes and recombinant cardiac (CaV1.2a) and vascular (CaV1.2b) splice variants of the channel expressed in HEK 293 cells. Haloperidol inhibited L-type calcium current in a concentration-dependent manner with a threshold of 1 nmol/l. 1 micromol/l haloperidol inhibited 20.6 +/- 3.6% of calcium current amplitude in cardiomyocytes, 25.4 +/- 2.6% of current amplitude through the CaV1.2b channel and 28.0 +/- 2.7% of current through the CaV1.2a channel. Inhibition was not accompanied by alteration of current waveform or by shift of current-voltage relation. In a current clamp haloperidol suppressed action potential generation. 1 micromol/l of the drug shortened the action potential duration in part of the cells and suppressed fully action potential in other cells. Moderate inhibition of the L-type calcium channels by haloperidol might cause shortening of action potential. Complete abolishment of action potential must have been mediated by inhibition of another, likely sodium channel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20037190     DOI: 10.4149/gpb_2009_03_249

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  7 in total

1.  Ca2+ signaling as a mechanism of haloperidol-induced cytotoxicity in human astrocytes and assessing the protective role of a Ca2+ chelator.

Authors:  Shu-Shong Hsu; Wei-Zhe Liang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-27       Impact factor: 3.000

2.  Sigma-1 receptor antagonist haloperidol attenuates Ca2+ responses induced by glutoxim and molixan in macrophages.

Authors:  Z I Krutetskaya; L S Milenina; A A Naumova; S N Butov; V G Antonov; A D Nozdrachev
Journal:  Dokl Biochem Biophys       Date:  2017-04-19       Impact factor: 0.788

3.  Sigma-1 Receptor Antagonist Haloperidol Attenuates Store-Dependent Ca2+ Entry in Macrophages.

Authors:  Z I Krutetskaya; L S Milenina; A A Naumova; S N Butov; V G Antonov; A D Nozdrachev
Journal:  Dokl Biochem Biophys       Date:  2018-07-14       Impact factor: 0.788

4.  Investigation of the Selectivity of L-Type Voltage-Gated Calcium Channels 1.3 for Pyrimidine-2,4,6-Triones Derivatives Based on Molecular Dynamics Simulation.

Authors:  Qi Ye; Zhenyu Zhang; Wenying Zhang; Yushan Ding; Fan Zhao; Jinghai Zhang; Yongbo Song
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

5.  Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating.

Authors:  José Alexandre Salerno; Thayana Torquato; Jairo R Temerozo; Livia Goto-Silva; Karina Karmirian; Mayara A Mendes; Carolina Q Sacramento; Natalia Fintelman-Rodrigues; Letícia R Q Souza; Isis M Ornelas; Carla P Veríssimo; Luiz Guilherme H S Aragão; Gabriela Vitória; Carolina S G Pedrosa; Suelen da Silva Gomes Dias; Vinicius Cardoso Soares; Teresa Puig-Pijuan; Vinícius Salazar; Rafael Dariolli; Diogo Biagi; Daniel R Furtado; Luciana Barreto Chiarini; Helena L Borges; Patrícia T Bozza; Marilia Zaluar P Guimarães; Thiago M L Souza; Stevens K Rehen
Journal:  PeerJ       Date:  2021-12-20       Impact factor: 2.984

Review 6.  Knocking Out Sigma-1 Receptors Reveals Diverse Health Problems.

Authors:  Simon Couly; Nino Goguadze; Yuko Yasui; Yuriko Kimura; Shao-Ming Wang; Nino Sharikadze; Hsiang-En Wu; Tsung-Ping Su
Journal:  Cell Mol Neurobiol       Date:  2020-10-23       Impact factor: 5.046

Review 7.  Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review.

Authors:  Amber N Edinoff; Emily D Ellis; Laura M Nussdorf; Taylor W Hill; Elyse M Cornett; Adam M Kaye; Alan D Kaye
Journal:  Neurol Int       Date:  2022-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.